Feb 24
|
Hims & Hers to 'treat multiple specialties,' not just weight loss
|
Feb 24
|
Hims & Hers stock tumbles despite beating Q4 revenue estimates
|
Feb 24
|
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
|
Feb 24
|
Estimating The Intrinsic Value Of Hims & Hers Health, Inc. (NYSE:HIMS)
|
Feb 21
|
Hims Stock Crashes After FDA Resolves Weight-Loss Drugs Shortage
|
Feb 21
|
Hims & Hers shares dive on end of weight loss drug shortage
|
Feb 21
|
CrowdStrike, Hims & Hers, Rivian: Market Minute
|
Feb 21
|
Hims & Hers Acquires US-based Peptide Facility
|
Feb 20
|
Apple unveils iPhone 16e, Arista reports Q4 beat: Morning Buzz
|
Feb 13
|
Senate confirms RFK Jr. as Trump's health secretary
|
Feb 13
|
Hims & Hers stock sees another spike in trading days after Super Bowl ad
|
Feb 12
|
Hims & Hers Option Trade Offers $410 Return Or 17% Discount
|
Feb 10
|
Stock Market Today: Nvidia Helps Boost Dow Jones Higher; Meta Keeps Rally AliveĀ (Live Coverage)
|
Feb 10
|
Super Bowl: AI ads just 'fell flat' during the big game
|
Feb 10
|
Hims & Hers Super Bowl ad stirs up controversy with lawmakers
|
Feb 10
|
Hims Super Bowl Ad Spotlights Weight-Loss Drug Copycats as Clock Ticks on Their Business
|